Go Pro

Lam Research Corporation $LRCX Shares Sold by Sapient Capital LLC

Lam Research logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Sapient Capital LLC cut its Lam Research stake by 91.6% in the second quarter, selling 6,033 shares and retaining 553 shares valued at approximately $240,000. Institutional investors still own 84.61% of the company.
  • Lam Research reported strong quarterly results, with revenue up 30% year over year to $6.72 billion and EPS of $1.82, exceeding analyst expectations. The company also raised its quarterly dividend from $0.26 to $0.33 per share, a roughly 27% increase.
  • Analysts maintain a broadly positive view, with the stock carrying a “Moderate Buy” consensus rating and an average price target of $358.97. However, recent insider selling and elevated valuation metrics remain potential concerns for investors.
  • MarketBeat previews the top five stocks to own by October 1st.

Sapient Capital LLC trimmed its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 91.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 553 shares of the semiconductor company's stock after selling 6,033 shares during the quarter. Sapient Capital LLC's holdings in Lam Research were worth $240,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Bayban acquired a new stake in Lam Research in the fourth quarter worth $26,000. Vermillion Wealth Management Inc. acquired a new position in Lam Research during the 1st quarter valued at about $26,000. Cedar Mountain Advisors LLC increased its stake in shares of Lam Research by 242.9% in the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company's stock valued at $26,000 after purchasing an additional 85 shares during the period. Paladin Partners LLC bought a new stake in shares of Lam Research during the second quarter valued at approximately $26,000. Finally, Mcguire Capital Advisors Inc. bought a new stake in shares of Lam Research during the fourth quarter valued at approximately $27,000. 84.61% of the stock is currently owned by institutional investors.

Lam Research Stock Performance

Lam Research stock opened at $307.65 on Friday. Lam Research Corporation has a fifty-two week low of $100.68 and a fifty-two week high of $438.50. The firm's 50 day simple moving average is $321.34 and its 200-day simple moving average is $291.39. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. The company has a market cap of $384.97 billion, a P/E ratio of 53.41, a price-to-earnings-growth ratio of 1.22 and a beta of 1.85.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The business had revenue of $6.72 billion during the quarter, compared to analysts' expectations of $6.66 billion. During the same quarter last year, the firm posted $1.33 earnings per share. Lam Research's revenue was up 30.0% compared to the same quarter last year. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, equities research analysts predict that Lam Research Corporation will post 9.33 EPS for the current year.

Lam Research Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 14th. Shareholders of record on Wednesday, September 23rd will be given a $0.33 dividend. This is a positive change from Lam Research's previous quarterly dividend of $0.26. This represents a $1.32 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Wednesday, September 23rd. Lam Research's payout ratio is presently 22.92%.

Analyst Ratings Changes

LRCX has been the topic of several analyst reports. Morgan Stanley lowered their target price on Lam Research from $404.00 to $367.00 and set an "overweight" rating on the stock in a research report on Thursday, July 30th. UBS Group decreased their price target on Lam Research from $435.00 to $425.00 and set a "buy" rating for the company in a research note on Tuesday, September 1st. B. Riley Financial lowered their price target on Lam Research from $385.00 to $350.00 and set a "buy" rating on the stock in a report on Thursday, July 30th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $320.00 price objective on shares of Lam Research in a research note on Thursday, July 30th. Finally, Rothschild & Co Redburn upped their price objective on shares of Lam Research from $305.00 to $420.00 and gave the stock a "buy" rating in a report on Wednesday, June 17th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $358.97.

Get Our Latest Stock Report on LRCX

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Lam Research’s record June-quarter results and outlook remain key catalysts. Revenue reached $6.72 billion, up 30% year over year, while adjusted earnings exceeded analysts’ expectations. Management guided for approximately $8.10 billion in September-quarter revenue, reinforcing confidence in continued AI- and advanced-chip-related demand. Lam Research gains as investors build on strong guidance and recent shareholder-friendly updates
  • Positive Sentiment: The company broke ground on a new Oregon research laboratory and plans to invest more than $3 billion in its global lab network over five years. The investment is intended to support semiconductor research tied to artificial intelligence and next-generation chip production. Lam Research Oregon laboratory announcement
  • Positive Sentiment: Lam Research raised its quarterly dividend by approximately 27% to $0.33 per share, improving the stock’s shareholder-return profile after its record quarter. Lam Research dividend increase
  • Positive Sentiment: Options activity and bullish institutional positioning may be adding to momentum. More than 1,600 institutions reportedly increased their holdings in the latest quarter, while recent analyst targets—including several between $400 and $500—remain above the current trading range. Lam Research options market article
  • Neutral Sentiment: The dividend increase has attracted attention as investors seek income and quality amid geopolitical and inflation concerns, although broader market volatility could continue to affect semiconductor stocks. Stocks with dividend hikes article
  • Negative Sentiment: Insiders have reported only sales—not purchases—in the past six months, including transactions by CEO Timothy Archer and other executives. That activity may raise concerns about valuation or profit-taking.
  • Negative Sentiment: After substantial long-term gains, some commentary argues that LRCX is fully valued, with elevated valuation metrics leaving less room for disappointment-free execution. UBS also recently lowered its price target to $425, despite remaining above the current share price. UBS lowers Lam Research price target

Insider Transactions at Lam Research

In related news, Director Eric Brandt sold 54,500 shares of the business's stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the sale, the director directly owned 199,205 shares in the company, valued at approximately $69,881,114. The trade was a 21.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 5,000 shares of the business's stock in a transaction on Monday, August 31st. The stock was sold at an average price of $302.46, for a total transaction of $1,512,300.00. Following the completion of the sale, the insider owned 42,462 shares of the company's stock, valued at $12,843,056.52. The trade was a 10.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 77,782 shares of company stock worth $26,755,370 in the last 90 days. 0.31% of the stock is owned by insiders.

Lam Research Company Profile

(Free Report)

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

See Also

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Lam Research Right Now?

Before you consider Lam Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.

While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines